These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3525045)

  • 1. Gastric protection by meciadanol. A new synthetic flavonoid inhibiting histidine decarboxylase.
    Konturek SJ; Kitler ME; Brzozowski T; Radecki T
    Dig Dis Sci; 1986 Aug; 31(8):847-52. PubMed ID: 3525045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of meciadanol on gastric secretion and aspirin-induced gastric mucosal injury in humans.
    Konturek SJ; Kitler ME; Kwiecien N; Obtulowicz W; Oleksy J; Kopp B
    Scand J Gastroenterol; 1984 Nov; 19(8):1099-103. PubMed ID: 6442798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histidine decarboxylase inhibition by O-methyl-3(+)catechin and gastric acid secretion in the cat.
    Albinus M; Frisch G; Hennings G
    Agents Actions; 1983 Apr; 13(2-3):249-51. PubMed ID: 6869127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histidine decarboxylase inhibition: a novel approach towards the development of an effective and safe gastric anti-ulcer drug.
    Parmar NS; Hennings G; Gulati OP
    Agents Actions; 1984 Dec; 15(5-6):494-9. PubMed ID: 6397982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric anti-ulcer activity of (+)-cyanidanol-3, a histidine decarboxylase inhibitor.
    Parmar NS; Ghosh MN
    Eur J Pharmacol; 1981 Jan; 69(1):25-32. PubMed ID: 7202511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protective effect of Meciadanol (O-methyl-3(+)-catechin) on experimental ulceration.
    Jayaraj AP; Lewin MR; Tovey FI; Kitler ME; Clark CG
    Eur J Pharmacol; 1988 Mar; 147(2):265-71. PubMed ID: 3366177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histamine and acute haemorrhagic lesions in rat gastric mucosa: prevention of stress ulcer formation by (+)-catechin, an inhibitor of specific histidine decarboxylase in vitro.
    Reimann HJ; Lorenz W; Fischer M; Frölich R; Meyer HJ; Schmal A
    Agents Actions; 1977 Mar; 7(1):69-73. PubMed ID: 871094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of gastric and intestinal antisecretory and protective effects of prostacyclin and its stable thia-imino-analogue (Hoe 892) in conscious rats.
    Konturek SJ; Brzozowski T; Radecki T; Pastucki I
    Prostaglandins; 1984 Oct; 28(4):443-53. PubMed ID: 6395196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gastric anti-ulcer activity of naringenin, a specific histidine decarboxylase inhibitor.
    Parmar NS
    Int J Tissue React; 1983; 5(4):415-20. PubMed ID: 6671888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gastric antisecretory activity of 3-methoxy-5,7,3'4'-tetrahydroxyflavan (ME)--a specific histidine decarboxylase inhibitor in rats.
    Parmar NS; Hennings G
    Agents Actions; 1984 Oct; 15(3-4):143-5. PubMed ID: 6524513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SU-840, a novel synthetic flavonoid derivative of sophoradin, with potent gastroprotective and ulcer healing activity.
    Brzozowski T; Konturek SJ; Kwiecien S; Pajdo R; Drozdowicz D; Sliwowski Z; Muramatsu M
    J Physiol Pharmacol; 1998 Mar; 49(1):83-98. PubMed ID: 9594413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinction between antiulcer effect and cytoprotection.
    Robert A; Lancaster C; Davis JP; Field SO; Nezamis JE
    Scand J Gastroenterol Suppl; 1984; 101():69-73. PubMed ID: 6599540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lansoprazole on ethanol-induced injury and PG synthetic activity in rat gastric mucosa.
    Fukuda T; Arakawa T; Shimizu Y; Ohtani K; Higuchi K; Kobayashi K
    J Clin Gastroenterol; 1995; 20 Suppl 2():S5-7. PubMed ID: 7594340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 12-sulfodehydroabietic acid monosodium salt (TA-2711), a new anti-ulcer agent, on gastric mucosal lesions induced by necrotizing agents and gastric mucosal defensive factors in rats.
    Onoda Y; Takido M; Magaribuchi T; Tamaki H
    Jpn J Pharmacol; 1990 Apr; 52(4):631-8. PubMed ID: 2342230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of gastric acid secretion in progression of acute gastric erosions induced by ischemia-reperfusion into gastric ulcers.
    Brzozowski T; Konturek PC; Konturek SJ; Drozdowicz D; Kwiecieñ S; Pajdo R; Bielanski W; Hahn EG
    Eur J Pharmacol; 2000 Jun; 398(1):147-58. PubMed ID: 10856459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nocloprost, a unique prostaglandin E2 analog with local gastroprotective and ulcer-healing activity.
    Konturek SJ; Brzozowski T; Drozdowicz D; Krzyzek E; Garlicki J; Majka J; Dembinski A; Stachura J; Amon I
    Eur J Pharmacol; 1991 Apr; 195(3):347-57. PubMed ID: 1868881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha-Fluoromethyl histidine. Inhibition of histidine decarboxylase in pylorus ligated rat.
    Bouclier M; Jung MJ; Gerhart F
    Biochem Pharmacol; 1983 May; 32(10):1553-6. PubMed ID: 6860344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ulcer formation and cytoprotection by acetazolamide.
    Robert A; Lancaster C; Davis JP; Kolbasa KP; Nezamis JE
    Eur J Pharmacol; 1985 Dec; 118(3):193-201. PubMed ID: 3866690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of histidine decarboxylase decrease basal gastric acid secretion in the rat.
    Westerberg VS; Geiger JD
    Pharmacol Biochem Behav; 1987 Nov; 28(3):419-22. PubMed ID: 3685079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of elcatonin, a synthetic analogue of eel calcitonin, on acute gastric and duodenal lesions and gastroduodenal function in rats].
    Takeuchi K; Furukawa O; Tanaka H; Nishiwaki H; Okabe S
    Nihon Yakurigaku Zasshi; 1986 Feb; 87(2):123-33. PubMed ID: 3699626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.